Business Wire

ExOne Showcases Ability to 3D Print Virtually Any Powder Material in New Corporate Video, “Let’s Make it Right”

20.10.2021 15:30:00 EEST | Business Wire | Press release

Share

The ExOne Company (Nasdaq: XONE), the global leader in industrial sand and metal 3D printers using binder jetting technology, today announced that it is open to developing virtually any powder material in partnership with manufacturers for their specific application.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211020005203/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The ExOne Company has released a new corporate video, "Let's Make it Right," showcasing the ability of its sustainable binder jetting technology to 3D print virtually any type of powder. ExOne has already qualified more than 20 metals, ceramics and composites for 3D printing, but is now developing materials such as pulverized concrete and other waste products with customers. (Photo: Business Wire)

The material flexibility and sustainability of ExOne’s patented binder jet 3D printing technology is showcased in a new corporate video unveiled today, “Let’s Make it Right.” The video is a celebration of ExOne’s employees and their accomplishments over more than 20 years as the company prepares to be acquired by Desktop Metal.

Beginning in the mid-1990s, ExOne pioneered the commercial development of MIT’s patented binder jet 3D printing process, which transforms powdered materials into precision parts or tooling at high speeds. An industrial printhead selectively deposits binder into a bed of powder particles creating a solid part one layer at a time, just like printing on sheets of paper.

The company’s RTS-300, launched in 1998, was the first commercially available metal binder jet system. ExOne later began binder jetting sand for metalcasting molds and cores. Today, ExOne has a portfolio of eight sand and metal 3D printing systems that can print a wide range of powders into highly dense parts, or even parts with controlled porosity, for specific applications.

“Binder jet 3D printing is one of the few additive manufacturing technologies that holds the promise of being an all-purpose manufacturing tool; it can print just about any powdered material into any form or functional purpose. In recent years, advancements in machine design and binder chemistries have helped us take a leap closer to that ultimate goal,” said Rick Lucas, ExOne Chief Technology Officer and VP of New Markets. “We are thankful to all of our former and current employees, as well as our R&D partners around the world, who have helped us advance binder jetting to where it is today and continue to support development efforts around this important green technology.”

Unique Material Flexibility in 3D Printing

Binder jetting is viewed as a desirable and sustainable production method, largely because of its high speed, low waste and cost, as well as broad material flexibility, which is just beginning to be untapped because of ExOne’s improvements in machine design and binder chemistries.

To achieve high-density parts, such as metals, the printed part is typically sintered in a furnace to fuse the particles together into a high-density solid object. Porous parts, often created with sand or other large-particle media, can also be infiltrated with resins or metals to achieve desired properties and create unique composites.

Two new case studies illustrate the broad range of ExOne’s binder jetting technology beyond traditional industrial applications:

  • Luxury sound system company, Deeptime, manufactures its speakers with 3D printed sand that is infiltrated with a proprietary solution to deliver material properties that are 86% more rigid than MDF, leading to double the sound damping compared to traditional speakers and much higher performance.
  • Carnegie Mellon University’s School of Architecture, meanwhile, is developing binder jetting of pulverized concrete and other recycled materials that are then infiltrated with resins for use as durable outdoor architectural pieces. This approach represents the future of cradle-to-grave, ecologically intelligent building design.

ExOne’s resin-infiltrated sand 3D printing for architectural restoration was a finalist in the 2021 Awards for Composites Excellence at CAMX, the Composites and Advanced Materials Expo.

Full Flexibility of Binder Jet 3D Printing

Among the broad categories of materials that ExOne can now develop to manufacturer specifications:

  • Aluminum alloys
  • Carbides
  • Copper and copper alloys
  • Nickel alloys
  • Nitrides
  • Oxides
  • Precious metal alloys, including silver and gold
  • Refractory metals, such as tungsten and molybdenum alloys
  • Sands
  • Stainless steels, such as 17-4PH, 316L and 304L
  • Titanium alloys, such as Ti64
  • Tool steels, such as M2 and H13
  • Waste products such as concrete and more

ExOne’s new corporate video is available at www.exone.com/MakeitRight.

About ExOne

ExOne (Nasdaq: XONE) is the pioneer and global leader in binder jet 3D printing technology. Since 1995, we’ve been on a mission to deliver powerful 3D printers that solve the toughest problems and enable world-changing innovations. Our 3D printing systems quickly transform powder materials — including metals, ceramics, composites and sand — into precision parts, metalcasting molds and cores, and innovative tooling solutions. Industrial customers use our technology to save time and money, reduce waste, improve their manufacturing flexibility, and deliver designs and products that were once impossible. As home to the world’s leading team of binder jetting experts, ExOne also provides specialized 3D printing services, including on-demand production of mission-critical parts, as well as engineering and design consulting. Learn more about ExOne at www.exone.com or on Twitter at @ExOneCo. We invite you to join with us to #MakeMetalGreen™.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sarah Webster
Chief Marketing Officer
724.516.2336
sarah.webster@exone.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 09:50:00 EET | Press release

Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto

ENHERTU ® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 09:30:00 EET | Press release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The application is based on data from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. In the trial, ENHERTU demo

NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 09:00:00 EET | Press release

NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term commitment to the Italian market, where the company has deep industrial roots

Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 03:18:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est

Perpetual Atomics Ltd, QSA Europe, QSA Global and Reef Origin to Collaborate on Building Radioisotope Power Systems in Europe18.2.2026 17:44:00 EET | Press release

Perpetual Atomics Ltd, QSA Europe (a trading name of Loma Systems s.r.o.), QSA Global, Inc., and Reef Origin signed an MOU in Prague to collaborate on the industrialized production of radioisotope power systems in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218036211/en/ Teams from Perpetual Atomics & QSA Global (USA and Czechia) at the facilities in Czechia This MOU builds on the existing collaboration between QSA Global, Inc. and Perpetual Atomics Ltd by expanding and strengthening the capacity and capability to produce radioisotope power systems in Europe. The key partnership with QSA Europe provides access to existing facilities, capabilities, knowledge, and know-how for the storage, handling, and distribution of commercial radioisotope systems for terrestrial applications. This capability is directly transferable to radioisotope power technologies for space. Radioisotope and nuclear power technologies are

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye